Skip to main content

Table 1 Baseline characteristics of the study population according to gender and MASLD grouping

From: The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective

 

Female

Male

Non-MASLD

MASLD

Standardize

Difference

(95% CI), %

Non- MASLD

MASLD

Standardize

Difference

(95% CI), %

Participants(n)

6362

478

 

5382

2029

 

CUN-BAE Index

29.28 (4.51)

37.14 (4.48)

175 (165, 184)

19.50 (4.11)

24.58 (4.20)

122 (117, 128)

Age (years)

42.89 (8.72)

47.64 (8.29)

56 (46, 65)

43.71 (9.27)

44.11 (8.20)

5 (0, 10)

Height(cm)

158.37(5.38)

157.04(5.28)

25 (16, 34)

170.89(6.04)

170.62(5.94)

5 (-1, 10)

Weight(kg)

51.86 (7.06)

63.17 (9.97)

131 (121, 141)

64.65 (8.34)

74.30 (10.56)

101 (96, 107)

BMI (kg/m2)

20.67 (2.57)

25.58 (3.57)

158 (148, 168)

22.12 (2.42)

25.48 (3.02)

123 (117, 128)

WC (cm)

70.80 (7.30)

83.27 (8.86)

154 (144, 163)

77.99 (6.77) 7

86.62 (7.37)

122 (116, 127)

ALT (IU/L)

13.00(11.00,17.00)

19.00(15.00,26.00)

63 (054, 073)

18.00(14.00,23.00)

29.00 (22.00,41.00)

93 (87, 98)

AST (IU/L)

16.00(13.00,19.00)

18.00(15.00,22.00)

35 (26, 44)

17.00 (14.00,21.00)

21.00(17.00,26.00)

54 (49, 60)

GGT (IU/L)

12.00 (9.00,14.00)

15.00 (12.00,20.00)

51 (41, 60)

17.00 (14.00,24.00)

24.00(18.00,35.00)

44 (38, 49)

HDL-C(mmol/L)

1.66 (0.38)

1.38 (0.34)

79 (70, 89)

1.35 (0.35)

1.14 (0.25)

68 (63, 74)

TC (mmol/L)

5.05 (0.86)

5.56 (0.92)

57 (47, 66)

5.06 (0.84)

5.41 (0.85)

42 (37, 47)

TG (mmol/L)

0.54 (0.40,0.77)

1.02 (0.73,1.38)

96 (87, 106)

0.80 (0.58,1.16)

1.32 (0.91,1.86)

75 (70, 80)

FPG (mmol/L)

4.96 (0.38)

5.27 (0.40)

79 (70, 88)

5.25 (0.37)

5.42 (0.35)

48 (43, 53)

HbA1c (%)

5.17 (0.32)

5.42 (0.33)

78 (69, 87)

5.13 (0.31)

5.27 (0.33)

45 (40, 50)

SBP (mmHg)

108.42 (13.77)

120.71 (16.04)

82 (73, 92)

116.04 (13.16)

124.04 (14.46)

58 (53, 63)

DBP (mmHg)

67.00 (9.48)

75.11 (10.22)

82 (73, 92)

72.88 (9.32)

78.44 (10.08)

57 (52, 62)

Exercise habits

1011 (15.89%)

68 (14.23%)

5 (-5, 14)

1082 (20.10%)

309 (15.23%)

13 (8, 18)

Drinking status

  

16 (6, 25)

  

25 (20, 30)

Non/minimal

5986 (94.09%)

465 (97.28%)

 

3731 (69.32%)

1623 (79.99%)

 

Light

376 (5.91%)

13 (2.72%)

 

1096 (20.36%)

273 (13.45%)

 

Moderate

0(0%)

0(0%)

 

555 (10.31%)

133 (6.55%)

 

Smoking status

  

4 (-5, 14)

  

6 (1, 11)

None

5609 (88.16%)

427 (89.33%)

 

1952 (36.27%)

758 (37.36%)

 

Past

382 (6.00%)

24 (5.02%)

 

1538 (28.58%)

615 (30.31%)

 

Current

371 (5.83%)

27 (5.65%)

 

1892 (35.15%)

656 (32.33%)

 
  1. Values were expressed as mean (SD) or medians (quartile interval) or n (%). Abbreviations: MASLD: metabolic dysfunction-associated steatotic liver disease; BMI: body mass index; WC: waist circumference; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyl transferase; HDL-C: high-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride; HbA1c: hemoglobin A1c; FPG: fasting plasma glucose; SBP: systolic blood pressure; DBP: diastolic blood pressure; CUN-BAE Index: Clínica Universidad de Navarra-Body Adiposity Estimator index